Section Arrow
PRAX.NASDAQ
- Praxis Precision Medicines
Quotes are at least 15-min delayed:2024/10/31 18:39 EDT
Last
 69.99
-0.035 (-0.05%)
Day High 
70.49 
Prev. Close
70.025 
1-M High
75.73 
Volume 
140.79K 
Bid
69.99
Ask
73.44
Day Low
67.5 
Open
70.37 
1-M Low
55.325 
Market Cap 
1.24B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 72.08 
20-SMA 69.27 
50-SMA 61.83 
52-W High 75.73 
52-W Low 13.005 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.59/-9.55
Enterprise Value
1.24B
Balance Sheet
Book Value Per Share
23.60
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
0.11
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ELABElevai Labs0.059-0.0339-36.49%-- 
AVTEAerovate Therapeutics2.46+0.27+12.33%-- 
ENSCEnsysce Biosciences0.5754-0.0629-9.85%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.1445-0.0099-6.41%-- 
GLYCGlycoMimetics0.4069-0.0496-10.87%-- 
Quotes are at least 15-min delayed:2024/10/31 18:39 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized bya neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.